Abstract:The treatment of locally advanced esophageal carcinoma remains a great challenge. For patients who are not surgical candidates, the majority of them are managed primarily with chemoradiation. However, radiation dose has been controversial. A prospective phase II study (ChiCTR-OIC-17010485) was conducted to determine the tolerance and efficacy of high dose intensity-modulated radiation therapy (IMRT) with concurrent chemotherapy for inoperable locally advanced esophageal squamous cell carcinoma (SCC). Eligibility criteria were: (1) histologically or cytologically proven esophageal SCC; (2) age 18-80 years; (3) Karnofsky performance status (KPS) ≥70; (4) clinical stages of I-IVA (AJCC,2002) with disease unresectable or inoperable, or the refusal of surgery; (5) no chemotherapy or surgery before enrollment; (6) normal liver, kidney and bone marrow functions; (7) no previous cancer history. Patients underwent IMRT for thoracic esophageal SCC. PTV1 composed of a 1.2-1.5 cm margin lateral around GTV and 3.0 cm margin superior/inferior of GTV. PTV2 encompassed GTV with a margin of 0.5-0.7 cm. The dose for PTV1 was 50 Gy in 2 Gy daily fractions; subsequently, PTV2 received a boost of 16 Gy in 2 Gy daily fractions to a total dose of 66 Gy. The concurrent chemotherapy regiments were fluorouracil (600mg/m2,d1-3) combined ciplatin (25mg/m2, d1-3) with 2 cycles and consolidate chemotherapy 2 cycles. A total of 86 patients were included with a median age of 64 years. The number of patients with stage I, II,III,IVA were 1,20,37 and 28, respectively. The median follow-up time was 19 months. None experienced CTCAE grade 4. The hematological toxicity with CTCAE grade 1,2,3 was 19%, 48.1% and 22.8%. The acute radiation esophagitis developed in 70% of patients with RTOG grades 1-2,and in 3.8% with grade 3. RTOG 1-2 radiation pneumonitis occurred in 20.8% of patients and in 1.3% with grade III. The rate of two-year overall survival, progression-free survival, distant metastasis and local control were 62.3%,35.5%,52.8% and 48.9%, respectively. Patients with inoperable locally advanced esophageal cancer received high dose of 66Gy IMRT with concurrent chemotherapy had a good tolerance and two-year overall survival was 62.3%. We warrant further studies evaluating the effectiveness of this approach compared with standard dose of 50.4Gy and chemotherapy.

Stereotactic Radiotherapy and Chemotherapy for Esophageal Carcinoma

Phase III Randomized Study of Preoperative Versus Postoperative Chemoradiotherapy in Resectable Locally Advanced Esophageal Squamous Cell Carcinoma

Clinical Study of Late-Course Three-Dimensional Conformal Radiotherapy for Esophageal Carcinoma

Clinical Study of Intensity Modulated Radiotherapy Combined with Chemotherapy in the Treatment of Non-surgical Patients with Locally Advanced Esophageal Carcinoma

STEREOTACTIC RADIOTHERAPY FOR 35 PATIENTS WITH PANCREATIC CANCER

461. SURGICAL TREATMENT OF STAGE IV ESOPHAGEAL CANCER AFTER CCRT IMPROVES SURVIVAL

Concurrent Three Dimensional Conformal Radiotherapy and Chemotherapy with DF Regime in the Treatment for 33 Cases with Advanced Esophageal Carcinoma

Effective Treatment of Esophageal Carcinomas Using Intensity-Modulated Radiotherapy in Combination with Nedaplatin and Docetaxel

The Efficacy of Three-Dimensional Conformal Late Course Accelerated Fractionation Radiotherapy for Esophageal Carcinoma

Phase 2 Study of Intensity-Modulated Radiation Therapy and Concurrent Chemotherapy for Inoperable Locally Advanced Esophageal Squamous Cell Carcinoma

Clinical Evaluation of Transarterial Infusion Chemotherapy for Advanced Esophageal Cancer

THE VALUE OF NEOADJUVANT THERAPY IN TREATMENTING ESOPHAGEAL CARCINOMA

Value of Radiotherapy After Radical Surgery for Esophageal Carcinoma: A Report of 495 Patients

Chemoradiotherapy Followed by Surgery Could Improve the Efficacy of Treatments in Patients with Resectable Esophageal Carcinoma

The Diagnosis and Treatment for Recurrent Dysphagia of Esophageal Carcinoma after Radical Radiotherapy

Late Course Accelerated Hyperfractionation Radiotherapy Combined with Chemotherapy for Elderly Patients with Esophageal Carcinoma

[Value of Postoperative Radiochemotherapy for Thoracic Esophageal Squamous Cell Carcinoma with Lymph Node Metastasis].

Conformal Radiotherapy for Esophageal Carcinoma in High-aged Patients

Different Radiation Treatment in Esophageal Carcinoma: a Clinical Comparative Study.

The Effect and Prognosis of Dimen sional Conformal Radiation Therapy for 1348 Cases Esophageal Carcinoma

Randomized controlled study on preoperative concurrent chemoradiotherapy versus surgery alone for esophageal squamous cell carcinoma